Notícias Eulerpool Cellectis

Cellectis Eulerpool-AFX

Cellectis Notícias de ações

Cellectis é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Cellectis nós reunimos aqui.

• 25 de julho ·

  Yahoo
  FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to Cellectis’ UCART22 product candidate for Acute Lymphoblastic Leukemia (ALL) Treatment
• 25 de julho ·

  TipRanks
  Cellectis Gains FDA Designations for Leukemia Therapy
• 25 de julho ·

  Thefly.com
  FDA grants Cellectis' UCART22 ODD and RPDD status for ALL treatment
• 23 de julho ·

  Thefly.com
  Cellectis treatment of acute lymphoblastic leukemia granted orphan designation
• 12 de julho ·

  Yahoo
  Regenxbio (RGNX) Surges 18.3%: Is This an Indication of Further Gains?
• 10 de julho ·

  Yahoo
  Down -22.78% in 4 Weeks, Here's Why You Should You Buy the Dip in Cellectis (CLLS)
• 5 de julho ·

  Yahoo
  Monthly information on share capital and company voting rights
• 28 de junho ·

  TipRanks
  Cellectis Shareholders Approve Key Resolutions
• 28 de junho ·

  TipRanks
  Cellectis Shareholders Support Management’s Vision
• 26 de junho ·

  GlobeNewswire
  Cibus Expands its Intellectual Property Coverage for Plant Gene Editing and Traits